Search - tctmd.com

Displaying 481 - 500 of 814

Sort: Relevancy | Date

News Daily News

Red Meat and Dairy Gut Metabolite Linked to Higher Mortality in PAD Patients

Michael O'Riordan

October 20, 2016

News Daily News

Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests

Todd Neale

October 19, 2016

News Daily News

Sin Sincronía: Los Monitores de Actividad No Marcan lo Mismo Cuando Miden la Frecuencia Cardíaca

L.A. McKeown

October 14, 2016

News Daily News

Out of Sync: Fitness Trackers Don’t Agree When It Comes to Measuring Heart Rate

L.A. McKeown

October 14, 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

Targeting PCI Readmissions at the Facility Level May Not Lessen Mortality: VA Study

Todd Neale

September 21, 2016

News Daily News

Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV

Michael O'Riordan

September 20, 2016

News Daily News

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Michael O'Riordan

September 16, 2016

News Daily News

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Michael O'Riordan

September 16, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Shelley Wood

September 13, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

The Hornet’s Nest of Data Sharing: Cardiologist-Led Proposals Do Not Necessarily Agree on Timelines, Reviews

Shelley Wood

August 03, 2016

News Daily News

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Yael L. Maxwell

August 03, 2016

News Daily News

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Todd Neale

July 25, 2016

News Daily News

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

Yael L. Maxwell

July 22, 2016

News Daily News

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Yael L. Maxwell

July 22, 2016

News Opinion Fellow Talk

Fellowships in Advanced Interventional and Structural Cardiology Need Structure, Planning, and Collaboration—Stat!

Ankur Kalra

July 05, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

Advertisement

Red Meat and Dairy Gut Metabolite Linked to Higher Mortality in PAD Patients

Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests

Sin Sincronía: Los Monitores de Actividad No Marcan lo Mismo Cuando Miden la Frecuencia Cardíaca

Out of Sync: Fitness Trackers Don’t Agree When It Comes to Measuring Heart Rate

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Targeting PCI Readmissions at the Facility Level May Not Lessen Mortality: VA Study

Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

The Bioresorbable Stent Story So Far: What Promise? What Price?

The Hornet’s Nest of Data Sharing: Cardiologist-Led Proposals Do Not Necessarily Agree on Timelines, Reviews

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Fellowships in Advanced Interventional and Structural Cardiology Need Structure, Planning, and Collaboration—Stat!

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content